** Shares in Sanofi SASY.PA drop around 3% as U.S. FDA appointed on Tuesday the agency critic Vinay Prasad as top vaccine official
** Prasad was appointed the director of the Center for Biologics Evaluation and Research (CBER), overseeing regulation of drugs, including vaccines
** Bernstein's analyst Florent Cespedes says Prasad's appointment put pharmaceutical stocks under pressure with vaccine companies being more impacted
** Shares in Sanofi, which is one of the world's largest vaccine makers by sales, trade at the bottom of France's blue-chip CAC 40 Index .FCHI
** They will see their worst day in almost a month, if losses hold
(Reporting by Michal Aleksandrowicz)
((michal.aleksandrowicz@tr.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。